HomeContact

Sicel Technologies, Inc.


Implantable sensors for oncology


Sicel was founded in July of 1999 by Dr. Charles Scarantino, an oncologist at Triangle Radiation Oncology Services practicing in the Rex Healthcare Cancer Center.


Michael D. Riddle, President, CEO, Director
Gloria Beyer, PhD, VP of Clinical Operations
Eric T. Espenhahn, VP of Engineering & Product Development
Tammy B. Carrea, Director of Regulatory Affairs
Greg G. Mann, Director of Engineering


Charles W. Scarantino, MD, PhD, Chairman
Michael D. Riddle
H. Troy Nagle, MD, PhD
Jonathan Gelles, PhD
Cheryl Sunderland


O. Michael Colvin, MD
George Washington Paschal, III, MD
Kenneth Wheeler, PhD


3800 Gateway Centre Blvd., Suite 308
Morrisville, NC 27560
USA
Phone: +1-919-465-2236
Fax: +1-919-465-0153


Sicel Technologies, Inc produces implantable wireless sensors in order to monitor biological and physiological changes in cell and organ systems. These sensors can give information about radiation dose, tissue microenvironment and/or gene expression to increase treatment success.

The company has developed OneDoseā„¢, which is a patient dosimetry verification system for specific use in radiation oncology therapy, and implantable sensors, which are implanted into unresectable, soild-mass tumours and monitor biological and physiological changes in organs and cells.

The following section contains a selection of the company’s most relevant patents. For comprehensive patent information please refer to the espacenet databases.